Discover how obesity drugs may reduce alcohol consumption alongside weight loss. Learn about this promising new research.

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

Discover how modern diabetes medications offer cardiovascular benefits, transforming diabetes care and improving outcomes worldwide.

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Regardless of the cell type, the researchers found that damage to the mitochondria did not cause cell death. This observation ...

Sales of Lilly’s top-selling product, the diabetes treatment Mounjaro, jumped 60% to $3.53 billion in the final quarter of 2024 while its obesity treatment counterpart Zepbound brought in $1.9 ...

A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...

PARIS, France — A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues, including dementia and cardiovascular diseases, although experts ...

Now, an analysis of studies has found that newer medications for type 2 diabetes may help reduce the risk of complications, particularly cardiovascular disease, in some people with type 2 diabetes.

The distinct population of endothelial cells that line blood vessels in the insulin-producing "islets" of the human pancreas ...